VIVITIDE Trademark

Trademark Overview


On Friday, May 8, 2020, a trademark application was filed for VIVITIDE with the United States Patent and Trademark Office. The USPTO has given the VIVITIDE trademark a serial number of 88906697. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Peptide Acquisition, Inc.. The VIVITIDE trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Distributorship services in the field of catalog and custom peptides, amino acid derivatives, enzymes, substrates and antibodies; Catalog ordering service featuring peptides, amino acid derivatives, enzymes, substrates and antibodies for research institutions and pharmaceutical companies

Consulting, research, development and analytical services in the field of pharmaceutical development; custom design and development of peptides and antibodies for research institutions and pharmaceutical companies

Custom manufacture of peptides and antibodies for research institutions and pharmaceutical companies

Biochemicals, chemical preparations and diagnostic preparations for in vitro and in vivo use in scientific and laboratory research and development, namely, amino acids, amino acid derivatives, antibodies, cytokines, enzyme inhibitors and substrates, growth factors, peptides, reagents for peptide synthesis, and recombinant proteins; chemical additives for use in the manufacture of pharmaceuticals

Chemical preparations for pharmaceutical or medical purposes, namely, for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; Diagnostic preparations for medical or veterinary purposes; Pharmaceutical preparations for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; vaccines
vivitide

General Information


Serial Number88906697
Word MarkVIVITIDE
Filing DateFriday, May 8, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6412529
Registration DateTuesday, July 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements


Goods and ServicesDistributorship services in the field of catalog and custom peptides, amino acid derivatives, enzymes, substrates and antibodies; Catalog ordering service featuring peptides, amino acid derivatives, enzymes, substrates and antibodies for research institutions and pharmaceutical companies
Goods and ServicesConsulting, research, development and analytical services in the field of pharmaceutical development; custom design and development of peptides and antibodies for research institutions and pharmaceutical companies
Pseudo MarkVIVITIDE
Goods and ServicesCustom manufacture of peptides and antibodies for research institutions and pharmaceutical companies
Goods and ServicesBiochemicals, chemical preparations and diagnostic preparations for in vitro and in vivo use in scientific and laboratory research and development, namely, amino acids, amino acid derivatives, antibodies, cytokines, enzyme inhibitors and substrates, growth factors, peptides, reagents for peptide synthesis, and recombinant proteins; chemical additives for use in the manufacture of pharmaceuticals
Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; Diagnostic preparations for medical or veterinary purposes; Pharmaceutical preparations for preventing or treating Alzheimer's disease, acromegaly, cancer, coronary syndromes, diabetes, diseases of the intestines, endometriosis, erectile dysfunction, glaucoma, growth hormone deficiency, hypoglycemia, myocardial infarction, Parkinson's disease, neurological diseases, rheumatic diseases, microbial diseases, virus infections and skin diseases; vaccines

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, May 19, 2020
Primary Code001
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 19, 2020
Primary Code005
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 4, 2020
Primary Code035
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, September 4, 2020
Primary Code040
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 19, 2020
Primary Code042
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

Trademark Owner History


Party NameBIOSYNTH INTERNATIONAL, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGardner, MA 01440
US

Party NameVIVITIDE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGARDNER, MA 01440
US

Party NameVIVITIDE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressGARDNER, MA 01440
US

Party NamePeptide Acquisition, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGardner, MA 01440
US

Party NamePeptide Acquisition, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGardner, MA 01440
US

Trademark Events


Event DateEvent Description
Tuesday, May 12, 2020NEW APPLICATION ENTERED
Tuesday, May 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 5, 2020ASSIGNED TO EXAMINER
Wednesday, August 12, 2020NON-FINAL ACTION WRITTEN
Wednesday, August 12, 2020NON-FINAL ACTION E-MAILED
Wednesday, August 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 17, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, May 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 17, 2021USE AMENDMENT FILED
Thursday, May 27, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, May 28, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 29, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, December 7, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 26, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 9, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED